Abstract
We report a genome-wide survey of early responses of the mouse heart transcriptome to acute myocardial infarction (AMI). For three regions of the left ventricle (LV), namely, ischemic/infarcted tissue (IF), the surviving LV free wall (FW), and the interventricular septum (IVS), 36,899 transcripts were assayed at six time points from 15 min to 48 h post-AMI in both AMI and sham surgery mice. For each transcript, temporal expression patterns were systematically compared between AMI and sham groups, which identified 515 AMI-responsive genes in IF tissue, 35 in the FW, 7 in the IVS, with three genes induced in all three regions. Using the literature, we assigned functional annotations to all 519 nonredundant AMI-induced genes and present two testable models for central signaling pathways induced early post-AMI. First, the early induction of 15 genes involved in assembly and activation of the activator protein-1 (AP-1) family of transcription factors implicates AP-1 as a dominant regulator of earliest post-ischemic molecular events. Second, dramatic increases in transcripts for arginase 1 (ARG1), the enzymes of polyamine biosynthesis, and protein inhibitor of nitric oxide synthase (NOS) activity indicate that NO production may be regulated, in part, by inhibition of NOS and coordinate depletion of the NOS substrate, L-arginine. ARG1 was the single-most highly induced transcript in the database (121-fold in IF region) and its induction in heart has not been previously reported.
Similar content being viewed by others
Abbreviations
- AMI:
-
acute myocardial infarction
- AP-1:
-
activator protein 1
- ARG1:
-
L-arginase 1
- ATF3:
-
activating transcription factor 3
- AZ:
-
antizyme inhibitor of ornithine decarboxylase
- AZI:
-
antizyme inhibitor releases ornithine decarboxylase from antizyme inhibition
- BNP:
-
brain natriuretic peptide
- CTGF:
-
connective tissue growth factor
- ERK:
-
extracellular signal regulated kinases
- FW:
-
left ventricular free wall
- HO-1:
-
heme oxygenase-1
- IF:
-
infarct
- IVS:
-
interventricular septum
- LV:
-
left ventricle
- MAPK:
-
mitogen activated protein kinase
- MCIP1:
-
modulatory calcineurin-interacting proteins
- MLP:
-
muscle LIM protein
- NO:
-
nitric oxide
- NOS:
-
nitric oxide synthase
- NFAT:
-
nuclear factor of activated t cells
- ODC:
-
ornithine decarboxylase
- PIN:
-
protein inhibitor of the NOS isozymes
- RT-PCR:
-
real time PCR
- SPDS:
-
spermidine synthase
- SSAT:
-
spermidine/spermine N-acetyltransferase
- SSAT:
-
spermidine/spermine N-acetyltransferase other gene names, see Supplementary Tables 1, 2, and 3.
References
Akiyama K, Akopian G, Jinadasa P, Gluckman TL, Terhakopian A, et al. (1997) Myocardial infarction and regulatory myosin light chain. J Mol Cell Cardiol 29:2641–2652
American Heart Association (AHA) (2003) Heart Disease and Stroke Statistics — 2004 Update (Dallas, TX: American Heart Association)
Arstall MA, Sawyer DB, Fukazawa R, Kelly RA (1999) Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85:829–840
Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, et al. (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337–339
Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC (2002) Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160:2035–2043
Bauer PM, Fukuto JM, Buga GM, Pegg AE, Ignarro LJ (1999) Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem Biophys Res Commun 262:355–358
Bauer PM, Buga GM, Fukuto JM, Pegg AE, Ignarro LJ (2001) Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem 276:34458–34464
Biggs TE, Cooke SJ, Barton CH, Harris MP, Saksela K, Mann DA (1999) Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events. J Mol Biol 290:21–35
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185–193
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, et al. (2001) The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res 88:88–96
Chattopadhyay MK, Tabor CW, Tabor H (2003) Polyamines protect Escherichia coli cells from the toxic effect of oxygen. Proc Natl Acad Sci USA 100:2261–2265
Chugh SS, Whitesel S, Turner M, Roberts CT Jr, Nagalla SR (2003) Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model. Cardiovasc Res 57:477–485
Corraliza IM, Campo ML, Soler G, Modolell M (1994) Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174:231–235
De Keulenaer GW, Wang Y, Feng Y, Muangman S, Yamamoto K, et al. (2002) Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy. Circ Res 90:690–696
Depre C, Tomlinson JE, Kudej RK, Gaussin V, Thompson E, et al. (2001) Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. Proc Natl Acad Sci USA 98:9336–9341
Dunsmuir P, Bond D, Lee K, Gidoni D, Townsend J (1987) The expression of introduced genes in regenerated plants. In: Plant Molecular Biology Manual, S. Gelvin and R. Schilperoort, eds. (Dordrecht: Kluwer Academic Publishers), pp 45–59
Eriksson M, Leppa S (2002) Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells. J Biol Chem 277:15992–16001
Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, et al. (2003) Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 57:749–756
Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79
Goetze JP (2004) ProBNP-derived peptides in cardiac disease. Scand J Clin Lab Invest 64:497–510
Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, et al. (2003) Ischemia–reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17:2328–2330
Hemmens B, Woschitz S, Pitters E, Klosch B, Volker C, et al. (1998) The protein inhibitor of neuronal nitric oxide synthase (PIN): characterization of its action on pure nitric oxide synthases. FEBS Lett 430:397–400
Hilfiker-Kleiner D, Kaminski K, Kaminska A, Fuchs M, Klein G, et al. (2004) Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 109:2227–2233
Holzberg D, Knight CG, Dittrich-Breiholz O, Schneider H, Dorrie A, et al. (2003) Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J Biol Chem 278:40213–40223
Hwang JJ, Allen PD, Tseng GC, Lam CW, Fananapazir L, et al. (2002) Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10:31–44
Jochum W, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401–2412
Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A (2002) Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol 22:5962–5974
Kapoun AM, Liang F, O’Young G, Damm DL, Quon D, et al. (2004) B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453–461
Kempf T, Wollert KC (2004) Nitric oxide and the enigma of cardiac hypertrophy. Bioessays 26:608–615
Kishimoto I, Rossi K, Garbers DL (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98:2703–2706
Kitakaze M, Asakura M, Sakata Y, Asanuma H, Sanada S, et al. (2001) cDNA array hybridization reveals cardiac gene expression in acute ischemic murine hearts. Cardiovasc Drugs Ther 15:125–130
Klee CB, Ren H, Wang X (1998) Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273:13367–13370
Kumar NV, Bernstein LR (2001) Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA. J Biol Chem 276:32362–32372
Laderoute KR, Calaoagan JM, Knapp M, Johnson RS (2004) Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun. Mol Cell Biol 24:4128–4137
Laframboise WA, Bombach KL, Dhir RJ, Muha N, Cullen RF, et al. (2005) Molecular dynamics of the compensatory response to myocardial infarct. J Mol Cell Cardiol 38:103–117
Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR (2003) Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 100:4843–4848
Leinwand LA (2001) Calcineurin inhibition and cardiac hypertrophy: A matter of balance. Proc Natl Acad Sci USA 98:2947–2949
Lyn D, Liu X, Bennett NA, Emmett NL (2000) Gene expression profile in mouse myocardium after ischemia. Physiol Genomics 2:93–100
Ma Q, Baldwin KT, Renzelli AJ, McDaniel A, Dong L (2001) TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 289:499–506
Massion PB, Feron O, Dessy C, Balligand JL (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93:388–398
Matsui Y, Sadoshima J (2004) Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 37:477–481
Matsushita K, Umezawa A, Iwanaga S, Oda T, Okita H, et al. (1999) The EAT/mcl-1 gene, an inhibitor of apoptosis, is up-regulated in the early stage of acute myocardial infarction. Biochim Biophys Acta 1472:471–478
Mirotsou M, Watanabe CM, Schultz PG, Pratt RE, Dzau VJ (2003) Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol Genomics 15:115–126
Molkentin JD, Dorn IG 2nd (2001) Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391–426
Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, et al. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228
Morris SM Jr (2004) Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care 7:45–51
Muegge K, Williams TM, Kant J, Karin M, Chiu R, et al. (1989) Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 246:249–251
Mungrue IN, Gros R, You X, Pirani A, Azad A, et al. (2002) Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109:735–743
Nilsson J, Grahn B, Heby O (2000) Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem J 346 Pt 3:699–704
Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, et al. (2000) A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 278:H1049–1055
Omura T, Yoshiyama M, Yoshida K, Nakamura Y, Kim S, et al. (2002) Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine. Hypertension 39:81–86
Onody A, Zvara A, Hackler L Jr, Vigh L, Ferdinandy P, et al. (2003) Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 536:35–40
Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, et al. (1998) Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274:H1812–1820
Purcell NH, Darwis D, Bueno OF, Muller JM, Schule R, et al. (2004) Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 24:1081–1095
Raser JM, O’Shea EK (2004) Control of stochasticity in eukaryotic gene expression. Science 304:1811–1814
Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, et al. (2001) Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98:3328–3333
Rothermel BA, Vega RB, Williams RS (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15–21
Schneider A, Fischer A, Weber D, von Ahsen O, Scheek S, et al. (2004) Restriction-mediated differential display (RMDD) identifies pip92 as a pro-apoptotic gene product induced during focal cerebral ischemia. J Cereb Blood Flow Metab 24:224–236
Sears CE, Ashley EA, Casadei B (2004) Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos Trans R Soc Lond B Biol Sci 359:1021–1044
Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, et al. (2000) Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101:1990–1999
Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390–2400
Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–136
Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, et al. (1998) Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res 38:116–124
Simkhovich BZ, Marjoram P, Poizat C, Kedes L, Kloner RA (2003) Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study. Cardiovasc Res 59:450–459
Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 9:43–51
Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, et al. (2000) Altered patterns of gene expression in response to myocardial infarction [see comments]. Circ Res 86:939–945
Steenman M, Chen YW, Le Cunff M, Lamirault G, Varro A, et al. (2003) Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 12:97–112
Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S (2004) Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 279:36167–36170
Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, et al. (2004) Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16:349–360
Tongers J, Fiedler B, Konig D, Kempf T, Klein G, et al. (2004) Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. Cardiovasc Res 63:545–552
Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, et al. (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci U S A 100:669–674
Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376:1–14
Weinberg EO, Mirotsou M, Gannon J, Dzau VJ, Lee RT, et al. (2003) Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 12:113–127
Xi L, Taher M, Yin C, Salloum F, Kukreja RC (2004) Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol 287:H2369–2375
Yamamoto K, Ohki R, Lee RT, Ikeda U, Shimada K (2001) Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 104:1670–1675
Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, et al. (2000) Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102:3046–3052
Yao Z, Zhou G, Wang XS, Brown A, Diener K, Gan H, et al. (1999) A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J Biol Chem 274:2118–2125
Yasukawa H, Hoshijima M, Gu Y, Nakamura T, et al. (2001) Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 108, 1459–1467
Zhao M, Chow A, Powers J, Fajardo G, Bernstein D (2004) Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics 19:93–105
Zingarelli B, Hake PW, O’Connor M, Denenberg A, Wong HR, et al. (2004) Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am J Physiol Heart Circ Physiol 286:H1408–1415
Ziolo MT, Bers DM (2003) The real estate of NOS signaling: location, location, location. Circ Res 92:1279–1281
Zubakov D, Hoheisel JD, Kluxen FW, Brandle M, Ehring T, et al. (2003) Late ischemic preconditioning of the myocardium alters the expression of genes involved in inflammatory response. FEBS Lett 547:51–55
Acknowledgments
This study was supported by grants from the National Institutes of Health [NCRR P20 RR15640 (COBRE) and NIH 1 R15 HL71239-01]. The authors thank Drs. Stephen Bieber and Tzulip Phang for consultation on statistical analyses. They also thank Todd Woessner of the Microarray Core Facility (University of Colorado Health Sciences Center at Denver) for GeneChip processing.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mark H. Harpster and Somnath Bandyopadhyay contributed equally to this work.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Harpster, M.H., Bandyopadhyay, S., Thomas, D.P. et al. Earliest changes in the left ventricular transcriptome post-myocardial infarction. Mamm Genome 17, 701–715 (2006). https://doi.org/10.1007/s00335-005-0120-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-005-0120-1